Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Immunity to cancer through immune recognition of altered self: studies with melanoma.

Guevara-PatiƱo JA, Turk MJ, Wolchok JD, Houghton AN.

Adv Cancer Res. 2003;90:157-77. Review.

PMID:
14710950
2.

Multiple pathways to tumor immunity and concomitant autoimmunity.

Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN.

Immunol Rev. 2002 Oct;188:122-35. Review.

PMID:
12445286
3.

Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.

Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton AN.

Oncogene. 2003 May 19;22(20):3180-7. Review.

PMID:
12789294
4.

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH.

Adv Immunol. 2006;90:243-95. Review.

PMID:
16730266
5.

Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.

Uchi H, Stan R, Turk MJ, Engelhorn ME, Rizzuto GA, Goldberg SM, Wolchok JD, Houghton AN.

Adv Immunol. 2006;90:215-41. Review.

PMID:
16730265
6.

Melanoma vaccines.

Perales MA, Wolchok JD.

Cancer Invest. 2002;20(7-8):1012-26. Review.

PMID:
12449735
7.

How the immune system achieves self-nonself discrimination during adaptive immunity.

Jiang H, Chess L.

Adv Immunol. 2009;102:95-133. doi: 10.1016/S0065-2776(09)01202-4. Review.

PMID:
19477320
8.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Peggs KS, Quezada SA, Allison JP.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Review.

PMID:
18759925
9.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587
11.

When T cells recognize a pattern, they might cause trouble.

Sospedra M, Martin R.

Curr Opin Immunol. 2006 Dec;18(6):697-703. Epub 2006 Sep 28. Review.

PMID:
17010587
12.

Newly identified tumor antigens as promising cancer vaccine targets for malignant melanoma treatment.

Ferrucci PF, Tosti G, di Pietro A, Passoni C, Pari C, Tedeschi I, Cataldo F, Martinoli C, Testori A.

Curr Top Med Chem. 2012;12(1):11-31. Review.

PMID:
22196269
13.
14.

Immunology and breast cancer: therapeutic cancer vaccines.

Curigliano G, Rescigno M, Goldhirsch A.

Breast. 2007 Dec;16 Suppl 2:S20-6. Epub 2007 Aug 13. Review.

PMID:
17706425
15.

Augmenting T helper cell immunity in cancer.

Knutson KL, Disis ML.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):365-71. Review.

PMID:
16375690
16.

Ovarian tumour antigens as potential targets for immune gene therapy.

Kuiper M, Peakman M, Farzaneh F.

Gene Ther. 1995 Jan;2(1):7-15. Review.

PMID:
7712335
17.

Melanoma cancer vaccines and anti-tumor T cell responses.

Vujanovic L, Butterfield LH.

J Cell Biochem. 2007 Oct 1;102(2):301-10. Review.

PMID:
17647270
18.

Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment.

Gajewski TF.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2326s-2330s. Review.

19.
20.

Targets of protective tumor immunity.

Dranoff G.

Ann N Y Acad Sci. 2009 Sep;1174:74-80. doi: 10.1111/j.1749-6632.2009.04938.x. Review.

PMID:
19769739

Supplemental Content

Support Center